Identification and Characterization of a Novel Single Domain Antibody Against Ebola Virus
Author:
Publisher
Elsevier BV
Subject
Virology,Molecular Medicine,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s12250-021-00454-z.pdf
Reference38 articles.
1. Agnolon V, Kiseljak D, Wurm MJ, Wurm FM, Foissard C, Gallais F, Wehrle S, Muñoz-Fontela C, Bellanger L, Correia BE, Corradin G, Spertini F (2020) Designs and characterization of subunit Ebola GP vaccine candidates: implications for immunogenicity. Front Immunol 11:586595
2. Cao G, Gao X, Zhan Y, Wang Q, Zhang Z, Dimitrov DS, Gong R (2020) An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific binding. Mabs 12:1689027
3. Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, Shi W, Choe M, Marcus H, Thompson EA, Cagigi A, Silacci C, Fernandez-Rodriguez B, Perez L, Sallusto F, Vanzetta F, Agatic G, Cameroni E, Kisalu N, Gordon I, Ledgerwood JE, Mascola JR, Graham BS, Muyembe-Tamfun JJ, Trefry JC, Lanzavecchia A, Sullivan NJ (2016) Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science 351:1339–1342
4. Das DK, Bulow U, Diehl WE, Durham ND, Senjobe F, Chandran K, Luban J, Munro JB (2020) Conformational changes in the Ebola virus membrane fusion machine induced by pH, Ca2+, and receptor binding. PLoS Biol 18:e3000626
5. Davey RT, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, Beigel J, Tierney J, Lane HC, Fauci AS, Massaquoi MBF, Sahr F, Malvy D (2016) A randomized, controlled trial of ZMapp for Ebola virus infection. N Engl J Med 375:1448–1456
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A review on camelid nanobodies with potential application in veterinary medicine;Veterinary Research Communications;2024-06-13
2. Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus;Acta Naturae;2024-05-10
3. Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication;Virologica Sinica;2023-12
4. Emerging Pathogenic Viral Infections of the Eye;Annual Review of Vision Science;2023-09-15
5. Ebanga™: The most recent FDA-approved drug for treating Ebola;Frontiers in Pharmacology;2023-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3